尺蠖效应:基于扎根理论的医药企业战略再导向研究

Inchworm Effect: Study on Strategic Re-orientation of Pharmaceutical and Biotechnology Firms Based on Grounded Theory Building

论文研究中国医药企业是如何进行战略再导向的,以及何种因素影响着战略导向的选择。战略再导向指企业改变战略路径,从一种战略导向转至另外一种战略导向的选择过程。论文从背景、过程、内容三个角度建立研究框架;采取扎根理论建构的方法构建模型。研究发现,国内医药企业战略再导向除受制度环境、市场环境、企业资源等因素影响外,管理者认知对外部环境和再导向的关系起着中介作用,组织惯性具有调节作用,制度执行力是制度环境的重要组成部分。因转型经济特殊性和产业特点,医药企业战略再导向存在着不断的在市场导向和技术导向间摇摆的尺蠖效应。研究揭开了企业战略再导向过程的黑箱,解释了为何在新兴经济中,医药企业战略再导向相对于制度和市场环境的规范化有着普遍的滞后。

This paper studies how Chinese pharmaceutical and biotechnology firms change their strategic orientation and what factors influence this process. Strategic re-orientation means firms change their strategic path. It is a strategy selection process in which firms switch from the original strategic orientation to a new one. We establish a research framework from the context,process and content perspective. We use grounded theory method to build our model. The study finds that the strategic re-orientation of domestic pharmaceutical enterprises is not only affected by institutional environment,market environment and corporate resources. Managers＇ cognition is a mediator between the environment and the re-orientation. Organizational inertia has a moderator role. Institutional enforcement is an important part of the institutional environment. There is an inchworm effect of strategic re-orientation which means pharmaceutical and biotechnology firms swing between technology orientation and market orientation because of the characteristics of emerging economies and the special nature of the industry. The research opens the black box of the process of strategic re-orientation and explains why there exists a lagged effect between the completeness of institutional and market environment and the strategic re-orientation in the pharmaceutical sector of emerging economies.